Earnings Ahead

IMPL - Impel NeuroPharma

1.13 -0.05 -4.24

Impel NeuroPharma

Impel NeuroPharma

About

Profile


Headquarters

Seattle, Washington, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

IMPL



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Impel NeuroPharma Non-GAAP EPS of -$0.97 beats by $0.06, revenue of $5.01M misses by $0.24M
  • Impel Pharma says reducing headcount by 16%, eliminating pipeline programs
  • Impel cut to Neutral at Wedbush on sales outlook for migraine therapy
  • Impel NeuroPharma GAAP EPS of -$1.31 misses by $0.32, revenue of $3.1M misses by $2.65M
  • Impel NeuroPharma GAAP EPS of -$1.09 misses by $0.04, revenue of $2.8M misses by $1.04M
  • Impel stock rises as dosing begins in mid-stage trial of INP105 for agitation in autistic people
  • Impel NeuroPharma Non-GAAP EPS of -$1.17 misses by $0.16, revenue of $1.8M in-line
  • Global Blood, Impel Pharma could be M&A targets after Biohaven deal - analysts
  • Impel NeuroPharma Non-GAAP EPS of -$1.07
  • Impel NeuroPharma announces $100M royalty and debt financing deal with Oaktree
  • Impel NeuroPharma migraine spray Q4 2021 prescriptions exceed company expectations
  • Impel NeuroPharma EPS misses by $0.48
  • Impel NeuroPharma forms partnership with Phil for Trudhesa
  • Impel Neuropharma picks Carepoint as a digital pharmacy partner for Trudhesa launch
  • Impel NeuroPharma launches Trudhesa nasal spray
  • Kadmon, Adagio top weekly healthcare gainers; Forte Biosciences and Humanigen trail
  • Impel NeuroPharma prices $45M stock offering
  • Impel NeuroPharma in red on 3M stock offering
  • Impel down 20% despite winning FDA approval for migraine nasal spray earlier in day
  • FDA approves Impel NeuroPharma's Trudhesa nasal spray for migraine

Earnings History

Date EPS / Forecast Revenue / Forecast
November 15, 2021 -1.24 / -0.75 100K / - Beat!
August 16, 2021 -0.79 / -0.6 - / -
June 7, 2021 -0.81 / -0.82 - / -
March 3, 2021 - / - - / -
Date Price Open High Low Vol Change ER
Sep 14, 2023 0.68 0.67
0.77
0.61
1.8M -15%
Sep 13, 2023 0.8 0.52
1.12
0.5
36.4M 45.45%
Sep 12, 2023 0.55 0.42
0.59
0.41
2.3M 34.15%
Sep 11, 2023 0.41 0.34
0.44
0.34
532K -2.38%
Sep 8, 2023 0.42 0.47
0.48
0.38
6.3M 10.53%
 
Sep 7, 2023 0.38 0.41
0.44
0.38
47.5K -5%
Sep 6, 2023 0.4 0.4
0.45
0.4
53.2K 0%
Sep 5, 2023 0.4 0.44
0.51
0.38
122K -11.11%
Sep 1, 2023 0.45 0.46
0.48
0.44
80.8K -2.17%
Aug 31, 2023 0.46 0.5
0.54
0.46
118K -4.17%
Aug 30, 2023 0.48 0.46
0.52
0.44
143K 2.13%
Aug 29, 2023 0.47 0.51
0.51
0.44
107K 0%
Aug 28, 2023 0.47 0.54
0.54
0.45
151K -7.84%
Aug 25, 2023 0.51 0.42
0.55
0.42
360K 15.91%
Aug 24, 2023 0.44 0.35
0.53
0.35
640K 18.92%
Aug 23, 2023 0.37 0.3
0.39
0.29
389K 19.35%
Aug 22, 2023 0.31 0.35
0.36
0.28
392K -11.43%
Aug 21, 2023 0.35 0.43
0.43
0.33
351K -7.89%
Aug 18, 2023 0.38 0.59
0.6
0.37
817K -39.68%
Aug 17, 2023 0.63 0.65
0.98
0.61
881K 1.61%
Aug 16, 2023 0.62 0.57
0.65
0.54
818K -42.59%
Aug 15, 2023 1.08 1.12
1.25
1.08
53.1K -6.09%
Aug 14, 2023 1.15 1.22
1.26
1.1
50.3K -4.17%
Aug 11, 2023 1.2 1.27
1.36
1.16
169K -8.4%
Aug 10, 2023 1.31 1.47
1.47
1.25
67.2K -5.07%
Aug 9, 2023 1.38 1.21
1.38
1.21
48.5K 13.11%
Aug 8, 2023 1.22 1.26
1.29
1.18
39.3K -3.17%
Aug 7, 2023 1.26 1.33
1.33
1.21
21.9K -3.82%
Aug 4, 2023 1.31 1.27
1.31
1.27
10.4K 3.15%
Aug 3, 2023 1.27 1.27
1.34
1.26
19.5K 0%
Aug 2, 2023 1.27 1.31
1.36
1.22
89.0K -5.93%
Aug 1, 2023 1.35 1.43
1.49
1.32
110K -4.93%
Jul 31, 2023 1.42 1.45
1.51
1.42
22.5K -2.07%
Jul 28, 2023 1.45 1.49
1.49
1.4
26.9K -2.68%
Jul 27, 2023 1.49 1.49
1.66
1.44
23.6K 2.05%
Jul 26, 2023 1.46 1.4
1.5
1.39
22.8K 1.39%
Jul 25, 2023 1.44 1.52
1.53
1.4
60.2K -7.69%
Jul 24, 2023 1.56 1.55
1.58
1.53
66.6K -1.27%
Jul 21, 2023 1.58 1.62
1.68
1.56
62.0K -3.66%
Jul 20, 2023 1.64 1.75
1.81
1.64
72.9K -6.29%
Jul 19, 2023 1.75 1.52
1.78
1.52
127K 8.70%
Jul 18, 2023 1.61 1.52
1.63
1.51
184K 3.21%
Jul 17, 2023 1.56 1.47
1.62
1.47
114K 5.41%
Jul 14, 2023 1.48 1.48
1.54
1.48
122K -1.33%
Jul 13, 2023 1.5 1.55
1.59
1.48
108K -6.25%
Jul 12, 2023 1.6 1.5
1.72
1.47
225K 9.59%
Jul 11, 2023 1.46 1.56
1.62
1.42
213K -4.58%
Jul 10, 2023 1.53 1.68
1.68
1.46
348K -7.27%
Jul 7, 2023 1.65 1.59
1.69
1.56
448K 5.10%
Jul 6, 2023 1.57 1.57
1.67
1.52
1.3M -7.65%
Jul 5, 2023 1.7 1.58
2.03
1.5
37.4M 36%
Jul 3, 2023 1.25 1.3
1.3
1.21
23.1K -1.57%
Jun 30, 2023 1.27 1.2
1.28
1.19
14.2K 4.96%
Jun 29, 2023 1.21 1.13
1.23
1.13
9.7K 6.14%
Jun 28, 2023 1.14 1.16
1.21
1.13
26.1K 0.88%
Jun 27, 2023 1.13 1.25
1.25
1.13
17.9K -4.24%
Jun 26, 2023 1.18 1.36
1.37
1.18
9.4K -4.07%
Jun 23, 2023 1.23 1.16
1.23
1.15
8.5K 3.36%
Jun 22, 2023 1.19 1.36
1.36
1.18
59.6K -8.46%
Jun 21, 2023 1.3 1.29
1.3
1.21
14.6K 0%